<?xml version="1.0" encoding="UTF-8"?>
<ref id="B39-pharmaceuticals-13-00283">
 <label>39.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Curvelo</surname>
    <given-names>J.A.R.</given-names>
   </name>
   <name>
    <surname>Marques</surname>
    <given-names>A.M.</given-names>
   </name>
   <name>
    <surname>Barreto</surname>
    <given-names>A.L.S.</given-names>
   </name>
   <name>
    <surname>Romanos</surname>
    <given-names>M.T.V.</given-names>
   </name>
   <name>
    <surname>Portela</surname>
    <given-names>M.B.</given-names>
   </name>
   <name>
    <surname>Kaplan</surname>
    <given-names>M.A.C.</given-names>
   </name>
   <name>
    <surname>Soares</surname>
    <given-names>R.M.A.</given-names>
   </name>
  </person-group>
  <article-title>A novel nerolidol-rich essential oil from 
   <italic>Piper claussenianum</italic> modulates 
   <italic>Candida albicans</italic> biofilm
  </article-title>
  <source>J. Med. Microbiol.</source>
  <year>2014</year>
  <volume>63</volume>
  <fpage>697</fpage>
  <lpage>702</lpage>
  <pub-id pub-id-type="doi">10.1099/jmm.0.063834-0</pub-id>
  <pub-id pub-id-type="pmid">24523158</pub-id>
 </element-citation>
</ref>
